首页|近红外二区荧光靶向探针在肝癌体内显像的应用研究

近红外二区荧光靶向探针在肝癌体内显像的应用研究

扫码查看
目的 探究半乳糖靶向纳米探针Gal-OH-BDP(GOB)在近红外二区(NIR-Ⅱ)进行原位肝癌荧光成像的可行性和成像效果。方法 合成NIR-Ⅱ纳米荧光探针GOB,通过人源HepG2肝癌细胞构建BALB/c裸鼠原位肝癌模型,将12只裸鼠采用简单随机抽样法分为2组,每组各6只。使用GOB瘤内注射法进行NIR-Ⅱ成像的记为NIR-Ⅱ GOB组,使用吲哚菁绿(ICG)静脉注射法并先后进行近红外一区(NIR-Ⅰ)和NIR-Ⅱ成像,分别记为NIR-Ⅰ ICG组和NIR-Ⅱ ICG组。利用NIR-Ⅰ/Ⅱ相机进行体内成像试验。使用Image J软件对图片进行荧光图像处理,定量计算肝癌荧光图像的肿瘤-正常组织比(TNR)和肿瘤边缘分辨率,通过石蜡切片及苏木精-伊红染色法进行病理学验证。样本数据采用t检验和方差分析。结果 通过病理学成功验证了瘤内注射后GOB在肝癌组织内的靶向积累。NIR-Ⅱ GOB组的TNR高于NIR-Ⅱ ICG组和NIR-Ⅰ ICG组(5。61±0。98比3。35±0。63比2。01±0。54,F=29。022,P<0。05)。对组成TNR的3项指标(肿瘤区域荧光、正常肝组织背景荧光和环境背景荧光)进行的亚组分析结果表明,在肿瘤区域荧光方面,NIR-Ⅱ GOB组高于 NIR-Ⅱ ICG 组(228。04±5。60 比 207。62±14。86,t=3。149,P<0。05);在正常肝组织背景荧光方面,NIR-Ⅱ GOB 组低于 NIR-Ⅱ ICG 组(43。22±8。68 比 63。47±8。88,t=-3。992,P<0。05)。通过计算跨越肿瘤边缘像素点的灰度值变化率来量化肿瘤边缘分辨率,NIR-Ⅱ GOB组高于NIR-Ⅱ ICG组和 NIR-Ⅰ ICG 组(170。01±30。92 比 98。96±23。99 比 36。82±10。19,F=48。882,P<0。05)。结论 通过瘤内注射Gal-OH-BDP纳米荧光团在NIR-Ⅱ窗口实现优于传统ICG介导的原位肝肿瘤荧光成像。
Application of the near infrared-Ⅱ fluorescent targeting probe in vivo imaging of liver cancer
Objective To explore the feasibility and imaging performance of galactose-targeted nanoprobe Gal-OH-BDP(GOB)for orthotopic hepatocelluar carcinoma in near infrared-Ⅱ(NIR-Ⅱ)fluo-rescence imaging.Methods NIR-Ⅱ fluorescent probe GOB was synthesized,and the orthotopic hepato-cellular carcinoma model of BALB/c nude mice(Hangzhou Ziyuan Experimental Animal Technology Co.,Ltd.)was established using human HepG2 hepatoma cells(Guangzhou Huatuo Biotechnology Co.,Ltd.).A total of 12 nude mice were randomly assigned into two groups using the simple random sampling,each consisting of 6 mice.Mice injected intratumorally with GOB for NIR-Ⅱ imaging were assigned into NIR-ⅡGOB group(6 cases),while those receiving intravenous injections of indocyanine green(ICG)and subse-quently imaged in both near infrared-Ⅰ(NIR-Ⅰ)and NIR-Ⅱ window were assigned into NIR-Ⅰ ICG group(6 cases)and NIR-Ⅱ ICG group(6 cases),respectively.The imaging experiment in vivo was car-ried out with NIR-Ⅰ/Ⅱ optical instruments.The fluorescence images were processed by Image J software,and the tumor-to-normal tissue ratio(TNR)and resolution of images of the tumor edge were quantitatively calculated.The pathology was verified by paraffin section and hematoxylin-eosin staining.The data were analyzed by t test and analysis of variance.Results Pathological validation confirmed the targeted accu-mulation of GOB in liver cancer tissues post-intratumoral injection.TNR in NIR-Ⅱ GOB group was higher than that in NIR-Ⅱ ICG group and NIR-Ⅰ ICG group(5.61±0.98 vs.3.35±0.63 vs.2.01±0.54,F=29.022,P<0.05).The subgroup analysis of three indexes of TNR(tumor region fluorescence,normal liver tissue background fluorescence and environmental background fluorescence)showed that in terms of tumor region fluorescence,the NIR-Ⅱ GOB group showed higher levels than the NIR-Ⅱ ICG group(228.04±5.60 vs.207.62±14.86,t=3.149,P<0.05).In the normal liver tissue background fluores-cence,the NIR-Ⅱ GOB group had lower fluorescence than the NIR-Ⅱ ICG group(43.22±8.68 vs.63.47±8.88,t=-3.992,P<0.05).By calculating the gray value change rate across the tumor edge pixels to quantify the resolution of images of the tumor edge,NIR-Ⅱ GOB group demonstrated higher tumor edge resolution than both the NIR-Ⅱ ICG and NIR-Ⅰ ICG groups(170.01±30.92 vs.98.96±23.99 vs.36.82±10.19,F=48.882,P<0.05).Conclusion This study achieved superior in orthotopic hepa-tocelluar carcinoma fluorescence imaging in the NIR-Ⅱ window through intratumoral injection of the Gal-OH-BDP nanoprobe,outperforming traditional ICG-mediated imaging.

Near infrared-ⅡFluorescence imagingOrthotopic liver tumorsGalactose-targeting

刘子豪、党慧萍、闫立峰、尹大龙

展开 >

安徽医科大学附属省立医院普外科,合肥 230001

中国安徽省合肥市中国科学技术大学化学物理系合肥微尺度物质科学国家实验室,合肥 230026

中国科学技术大学附属第一医院(安徽省立医院)先导医学与前沿技术研究所肝胆外科,合肥 230036

近红外二区 荧光成像 原位肝肿瘤 半乳糖靶向

国家自然科学基金安徽省重点研究与开发计划

82172071202104b1 1020025

2024

中华实验外科杂志
中华医学会

中华实验外科杂志

CSTPCD
影响因子:0.759
ISSN:1001-9030
年,卷(期):2024.41(7)
  • 3